uh-ah 37 has been researched along with darifenacin in 1 studies
Studies (uh-ah 37) | Trials (uh-ah 37) | Recent Studies (post-2010) (uh-ah 37) | Studies (darifenacin) | Trials (darifenacin) | Recent Studies (post-2010) (darifenacin) |
---|---|---|---|---|---|
7 | 0 | 0 | 165 | 28 | 54 |
Protein | Taxonomy | uh-ah 37 (IC50) | darifenacin (IC50) |
---|---|---|---|
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.3162 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.8322 | |
Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 1.5849 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gillberg, PG; Nilvebrant, L; Sundquist, S | 1 |
1 other study(ies) available for uh-ah 37 and darifenacin
Article | Year |
---|---|
Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
Topics: Animals; Benzhydryl Compounds; Benzodiazepinones; Benzofurans; Cats; Cerebral Cortex; CHO Cells; Cresols; Cricetinae; Dibenzazepines; Electric Stimulation; Female; Guinea Pigs; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Myocardium; Phenylpropanolamine; Piperidines; Pyrrolidines; Receptors, Muscarinic; Saliva; Salivary Glands; Tolterodine Tartrate; Urinary Bladder | 1998 |